Minimally Invasive Therapies for Osteoarthritic Hip Pain: a Comprehensive Review
Purpose of Review Osteoarthritis (OA) is a highly prevalent cause of chronic hip pain, affecting 27% of adults aged over 45 years and 42% of adults aged over 75 years. Though OA has traditionally been described as a disorder of “wear-and-tear,” recent studies have expanded on this understanding to include a possible inflammatory etiology as well, damage to articular cartilage produces debris in the joint that is phagocytosed by synovial cells which leads to inflammation. Recent Findings Patients with OA of the hip frequently have decreased quality of life due to pain and limited mobility though additional comorbidities of diabetes, cardiovascular disease, poor sleep quality, and obesity have been correlated. Initial treatment with conservative medical management can provide effective symptomatic relief. Physical therapy and exercise are important components of a multimodal approach to osteoarthritic hip pain. Patients with persistent pain may benefit from minimally invasive therapeutic approaches prior to consideration of undergoing total hip arthroplasty. Summary The objective of this review is to provide an update of current minimally invasive therapies for the treatment of pain stemming from hip osteoarthritis; these include intra-articular injection of medication, regenerative therapies, and radiofrequency ablation..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Current Review of Pain - 24(2020), 7 vom: 06. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Urits, Ivan [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Corticosteroids |
|---|
| doi: |
10.1007/s11916-020-00874-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR039959996 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR039959996 | ||
| 003 | DE-627 | ||
| 005 | 20230519215735.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11916-020-00874-8 |2 doi | |
| 035 | |a (DE-627)SPR039959996 | ||
| 035 | |a (SPR)s11916-020-00874-8-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Urits, Ivan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Minimally Invasive Therapies for Osteoarthritic Hip Pain: a Comprehensive Review |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Purpose of Review Osteoarthritis (OA) is a highly prevalent cause of chronic hip pain, affecting 27% of adults aged over 45 years and 42% of adults aged over 75 years. Though OA has traditionally been described as a disorder of “wear-and-tear,” recent studies have expanded on this understanding to include a possible inflammatory etiology as well, damage to articular cartilage produces debris in the joint that is phagocytosed by synovial cells which leads to inflammation. Recent Findings Patients with OA of the hip frequently have decreased quality of life due to pain and limited mobility though additional comorbidities of diabetes, cardiovascular disease, poor sleep quality, and obesity have been correlated. Initial treatment with conservative medical management can provide effective symptomatic relief. Physical therapy and exercise are important components of a multimodal approach to osteoarthritic hip pain. Patients with persistent pain may benefit from minimally invasive therapeutic approaches prior to consideration of undergoing total hip arthroplasty. Summary The objective of this review is to provide an update of current minimally invasive therapies for the treatment of pain stemming from hip osteoarthritis; these include intra-articular injection of medication, regenerative therapies, and radiofrequency ablation. | ||
| 650 | 4 | |a Hip osteoarthritis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Intra-articular injection |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Platelet-rich plasma |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Radiofrequency ablation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Viscosupplementation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hyaluronic acid |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Corticosteroids |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Orhurhu, Vwaire |e verfasserin |4 aut | |
| 700 | 1 | |a Powell, Jordan |e verfasserin |4 aut | |
| 700 | 1 | |a Murthy, Anu |e verfasserin |4 aut | |
| 700 | 1 | |a Kiely, Brendon |e verfasserin |4 aut | |
| 700 | 1 | |a Shipon, Samara |e verfasserin |4 aut | |
| 700 | 1 | |a Kaye, Rachel J. |e verfasserin |4 aut | |
| 700 | 1 | |a Kaye, Alan D. |e verfasserin |4 aut | |
| 700 | 1 | |a Arron, Brett L. |e verfasserin |4 aut | |
| 700 | 1 | |a Cornett, Elyse M. |e verfasserin |4 aut | |
| 700 | 1 | |a Viswanath, Omar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current Review of Pain |d Current Medicine Group, 1998 |g 24(2020), 7 vom: 06. Juni |w (DE-627)SPR023001666 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2020 |g number:7 |g day:06 |g month:06 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11916-020-00874-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2020 |e 7 |b 06 |c 06 | ||